123 related articles for article (PubMed ID: 11022696)
1. [Present status of serum total PSA assay and factors responsible for the inter-kit deviations].
Kano S
Nihon Rinsho; 2000 Jul; 58 Suppl():112-7. PubMed ID: 11022696
[No Abstract] [Full Text] [Related]
2. [The present status and future directions for standardization of PSA assays in PSA gray zone].
Kurokawa K; Yamanaka H; Ishibashi M; Kano S; Arai Y
Nihon Rinsho; 2002 Dec; 60 Suppl 11():117-22. PubMed ID: 12599556
[No Abstract] [Full Text] [Related]
3. [Determination of free type and complex type prostate-specific antigen (PSA): differences in immunorecognition by Delfia PSA, ACS-PSA and Eiken PA kits].
Sumi S; Umeda H; Koga F; Yano M; Imai T; Hosoya Y; Honda M; Maeda S; Suzuki T; Yoshida K; Negishi T
Hinyokika Kiyo; 1996 Apr; 42(4):279-84. PubMed ID: 8693960
[TBL] [Abstract][Full Text] [Related]
4. [Prostate-specific antigen and its related parameters in detecting prostate cancer].
Kuruma H; Egawa S
Gan To Kagaku Ryoho; 2003 Jan; 30(1):11-5. PubMed ID: 12557698
[TBL] [Abstract][Full Text] [Related]
5. [The present status of standardization in serum total PSA measurement--a result of "Survey 2000" conducted by PSA ad hoc Committee of Japanese Urological Association].
Kano S; Ishibashi M; Itoh Y;
Rinsho Byori; 2001 Oct; 49(10):967-73. PubMed ID: 11769473
[TBL] [Abstract][Full Text] [Related]
6. [Progress in standardization of total PSA immunoassays].
Ishibashi M
Rinsho Byori; 2004 Jul; 52(7):618-24. PubMed ID: 15344562
[TBL] [Abstract][Full Text] [Related]
7. [Free/total ratio of prostate-specific antigen (PSA) for prostate cancer detection in patients with gray zone PSA level].
Tanaka M; Murakami S; Igarashi T; Abe T; Suzuki K; Sekita N; Shimazaki J
Hinyokika Kiyo; 1997 Dec; 43(12):855-60. PubMed ID: 9488932
[TBL] [Abstract][Full Text] [Related]
8. [Clinical evaluation of a new kit (IMX PA Dainapack) for detection of serum prostate specific antigen].
Machida T; Ohishi Y; Wada T; Akimoto S; Shimazaki J; Oda H; Yokoyama M; Tsukada T; Nakayama T; Akiyama A
Hinyokika Kiyo; 1993 Oct; 39(10):977-84. PubMed ID: 7505519
[TBL] [Abstract][Full Text] [Related]
9. [Clinical significance of prostate specific antigen and gamma-seminoprotein ratio for diagnosing prostate cancer].
Akino H; Suzuki Y; Okada K
Nihon Rinsho; 1998 Aug; 56(8):2003-5. PubMed ID: 9750496
[TBL] [Abstract][Full Text] [Related]
10. [Comparison of 3 assay kits of prostate specific antigen in serum of prostatic cancer].
Akimoto S; Akakura K; Shimazaki J
Hinyokika Kiyo; 1988 Dec; 34(12):2143-8. PubMed ID: 2467543
[TBL] [Abstract][Full Text] [Related]
11. [The incidence of the variability of the free PSA/total PSA ratio on the early diagnosis of prostate cancer].
de La Taille A; Houlgatte A; Houdelette P; Berlizot P; Fournier R; Ricordel I
Prog Urol; 1997 Jun; 7(3):455-63. PubMed ID: 9273075
[TBL] [Abstract][Full Text] [Related]
12. [The significance of free-type PSA and complex-type PSA in patients with prostatic carcinoma--the characteristics of ACS-PSA method compared with that of Delfia- and Eiken-PSA method].
Arai K; Honda M; Hosoya Y; Sumi S; Umeda H; Yoshida K
Rinsho Byori; 1996 Apr; 44(4):345-50. PubMed ID: 8847816
[TBL] [Abstract][Full Text] [Related]
13. [Prostate-specific antigen as a tumor marker of prostate carcinoma].
Wymenga LF; Mensink HJ
Ned Tijdschr Geneeskd; 1999 Aug; 143(34):1733-8. PubMed ID: 10494319
[TBL] [Abstract][Full Text] [Related]
14. [Gamma-seminoprotein (gamma-Sm)].
Miyahara S
Nihon Rinsho; 2005 Aug; 63 Suppl 8():698-701. PubMed ID: 16149615
[No Abstract] [Full Text] [Related]
15. [The usefulness of prostate-specific antigen assay for the early detection and follow up of the prostate cancer].
Saito Y
Nihon Rinsho; 1998 Aug; 56(8):1989-93. PubMed ID: 9750493
[TBL] [Abstract][Full Text] [Related]
16. [Standardization of PSA assays].
Kuriyama M
Nihon Rinsho; 1998 Aug; 56(8):1998-2002. PubMed ID: 9750495
[TBL] [Abstract][Full Text] [Related]
17. Clinical usefulness of serum antip53 antibodies for prostate cancer detection: a comparative study with prostate specific antigen parameters.
Suzuki H; Akakura K; Igarashi T; Ueda T; Ito H; Watanabe M; Nomura F; Ochiai T; Shimada H
J Urol; 2004 Jan; 171(1):182-6. PubMed ID: 14665872
[TBL] [Abstract][Full Text] [Related]
18. [Value of prostate-specific antigen measurements with newly developed enzyme immunoassay (MARKIT-M PA)].
Arai Y; Onishi H; Oishi K; Takeuchi H; Yoshida O
Hinyokika Kiyo; 1992 Oct; 38(10):1129-34. PubMed ID: 1282772
[TBL] [Abstract][Full Text] [Related]
19. [Prostate cancer screening in total health care check--using serum PSA and AUA score].
Komeda Y; Soga N; Sato Y; Sato K; Suzuki R; Kawamura J
Hinyokika Kiyo; 1996 Apr; 42(4):275-8. PubMed ID: 8693959
[TBL] [Abstract][Full Text] [Related]
20. [Studies on changes in the ratio of free to total PSA after endocrine treatment of prostate carcinoma].
Sumi S; Umeda H; Yano M; Koga F; Arai K; Imai T; Hosoya Y; Maeda S; Honda M; Suzuki T; Yoshida K
Hinyokika Kiyo; 1996 Dec; 42(12):937-41. PubMed ID: 9013228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
